ArticleTargeted oncology2019

A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.

Thomas B Karasic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.